SuanNutra Acquires IFF Natural Ingredients Business

SuanNutra, a prominent player in the science-backed ingredients sector and backed by Carbyne Equity Partners, is significantly expanding its capabilities through the acquisition of a suite of specialty natural ingredient businesses from IFF. This strategic move, expected to finalize by year-end 2026 pending regulatory approval, integrates IFF's offerings into SuanNutra's existing framework, including its subsidiary Monteloeder, to forge a more robust global entity focused on natural solutions.

The acquisition is designed to propel SuanNutra into a new category leadership position, aligning with its core strategy of translating nutraceutical science into tangible market impact. The acquired businesses bring a wealth of clinically validated branded ingredients, proprietary botanical extraction facilities located in Spain and Peru, and advanced fermentation capabilities in the United States. This infusion also introduces a diverse range of plant-derived natural colors, antioxidants, and flavors, directly addressing the growing consumer demand for clean-label and natural alternatives in both the health and food industries.

This integration is set to create a formidable global operation. The combined manufacturing footprint will span botanical extraction across Spain, Slovenia, and Peru, complemented by fermentation expertise in the United States. The enlarged group anticipates employing approximately 700 individuals, serving a customer base exceeding 1,200 clients in over 60 countries. SuanNutra emphasizes a seamless transition for all customers, ensuring uninterrupted service and continued investment in commercial operations, research and development, and innovation across the expanded organization.

The transaction significantly enhances SuanNutra's "Visible Health" initiative, which champions ingredients with demonstrable wellness benefits backed by rigorous clinical evidence. Furthermore, the addition of natural colors, antioxidants, and flavors positions the company at the vanguard of the industry's pivot away from synthetic additives towards natural, sustainable ingredients. This aligns with a broader market trend where consumers increasingly prioritize transparency and natural sourcing in their food and supplement choices, a sector experiencing robust growth driven by health consciousness.

Anthony Weston, Group CEO of SuanNutra, highlighted the critical role of the acquired teams, stating, "The deep product and customer knowledge held by the people within these businesses is fundamental to our aspirations. Together, we will cultivate a stronger partner for our clients, offering end-to-end manufacturing, scientifically validated ingredients, and an extensive natural portfolio for both nutraceuticals and food enhancement."

Yoni Glickman, Non-Executive Chairman of SuanNutra, added, "The industry's trajectory is clearly towards clinically supported branded ingredients. This expansion firmly places SuanNutra at the forefront of this evolution, capitalizing on the accelerated shift towards natural, scientifically substantiated components in the food and health sectors." Markus Petersen, Managing Partner at Carbyne Equity Partners, expressed confidence in the merger's potential, noting, "This transaction establishes a botanical-based ingredients group with significant scale and scientific credibility. We are pleased to support the team in this transformative growth phase." Mai Karas, Investment Director at Carbyne Equity Partners, reiterated the firm's strategic focus, stating, "Specialty ingredients are central to Carbyne's investment thesis, and this acquisition broadens our global reach in natural ingredients while deepening our sector expertise."